Selective retina therapy enhanced with optical coherence tomography for dosimetry control and monitoring: a proof of concept study

Biomed Opt Express. 2018 Jun 26;9(7):3320-3334. doi: 10.1364/BOE.9.003320. eCollection 2018 Jul 1.

Abstract

Selective treatment of the retinal pigment epithelium (RPE) by using short-pulse lasers leads to a less destructive treatment for certain retinal diseases in contrast to conventional photocoagulation. The introduction of selective retina therapy (SRT) to clinical routine is still precluded by the challenges to reliably monitor treatment success and to automatically adjust dose within the locally varying therapeutic window. Combining micrometer-scale depth resolving capabilities of optical coherence tomography (OCT) with SRT can yield real-time information on the laser-induced changes within the RPE after a laser pulse or even during treatment with a laser pulse train. In the present study, SRT and OCT were combined to treat ex-vivo porcine eyes demonstrating closed-loop dose-control. We found a reliable correlation of specific signal changes in time resolved OCT images and physiological lesions in the RPE. First experiments, including 23 porcine eyes, prove the feasibility of the novel treatment concept.

Keywords: (170.0170) Medical optics and biotechnology; (170.4460) Ophthalmic optics and devices; (170.4500) Optical coherence tomography.